|
|
||||||||
American Journal of Clinical Nutrition, Vol 66, 606-610, Copyright © 1997 by The American Society for Clinical Nutrition, Inc
ORIGINAL RESEARCH COMMUNICATIONS |
MR Langlois, JR Delanghe, ML De Buyzere, DR Bernard and J Ouyang
Central Laboratory, University Hospital Gent, Belgium.
Haptoglobin is a hemoglobin-binding antioxidant showing a genetic polymorphism with three types: Hp 1-1, Hp 2-1, and Hp 2-2. The Hp 2-2 type has been associated with an increased risk of atherosclerosis. We investigated vitamin C metabolism in vivo and in vitro according to haptoglobin type in a study group of 135 healthy volunteers. Serum vitamin C concentrations were associated with haptoglobin type, showing lowest values in serum from Hp 2-2 subjects (P < 0.01). Renal threshold for L-ascorbic acid was within the normal range and metabolization to oxalate was not different among haptoglobin-type groups. Serum concentrations of other endogenous antioxidants (uric acid, bilirubin, albumin, ceruloplasmin, and total antioxidative status) were not different among haptoglobin-type groups. In vitro experiments showed a lower stability of L-ascorbic acid in blood from subjects with the Hp 2- 2 type (P < 0.01). L-Ascorbic acid depletion in vitro was inversely related to haptoglobin concentration (r = -0.738). The results of this study indicate a higher rate of L-ascorbic acid oxidation in Hp 2-2 carriers because they have less protection against hemoglobin-iron driven peroxidation.
This article has been cited by other articles:
![]() |
J. R. Delanghe, M. R. Langlois, M. L. De Buyzere, and M. A. Torck Vitamin C Deficiency and Scurvy Are Not Only a Dietary Problem but Are Codetermined by the Haptoglobin Polymorphism Clin. Chem., August 1, 2007; 53(8): 1397 - 1400. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Asleh, J. Guetta, S. Kalet-Litman, R. Miller-Lotan, and A. P. Levy Haptoglobin Genotype- and Diabetes-Dependent Differences in Iron-Mediated Oxidative Stress In Vitro and In Vivo Circ. Res., March 4, 2005; 96(4): 435 - 441. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. R. Delanghe and M. L. De Buyzere Development of an ELISA for the Determination of the Major Haptoglobin Phenotype: An Interesting Technical Development and Its Potential Consequences Clin. Chem., November 1, 2004; 50(11): 1972 - 1973. [Full Text] [PDF] |
||||
![]() |
S. Mustafa, T. Vukovich, T. Prikoszovich, C. Winzer, B. Schneider, H. Esterbauer, O. Wagner, and A. Kautzky-Willer Haptoglobin Phenotype and Gestational Diabetes Diabetes Care, September 1, 2004; 27(9): 2103 - 2107. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. P. Levy, P. Friedenberg, R. Lotan, P. Ouyang, M. Tripputi, L. Higginson, F. R. Cobb, J.-C. Tardif, V. Bittner, and B. V. Howard The Effect of Vitamin Therapy on the Progression of Coronary Artery Atherosclerosis Varies by Haptoglobin Type in Postmenopausal Women Diabetes Care, April 1, 2004; 27(4): 925 - 930. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Davey Smith and S. Ebrahim 'Mendelian randomization': can genetic epidemiology contribute to understanding environmental determinants of disease? Int. J. Epidemiol., February 1, 2003; 32(1): 1 - 22. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Kasvosve, J. R Delanghe, Z. A. Gomo, I. T Gangaidzo, H. Khumalo, M. R Langlois, V. M Moyo, T. Saungweme, E. Mvundura, J. R Boelaert, et al. Effect of transferrin polymorphism on the metabolism of vitamin C in Zimbabwean adults Am. J. Clinical Nutrition, February 1, 2002; 75(2): 321 - 325. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Melamed-Frank, O. Lache, B. I. Enav, T. Szafranek, N. S. Levy, R. M. Ricklis, and A. P. Levy Structure-function analysis of the antioxidant properties of haptoglobin Blood, December 15, 2001; 98(13): 3693 - 3698. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. R. Langlois, M.-E. Martin, J. R. Boelaert, C. Beaumont, Y. E. Taes, M. L. De Buyzere, D. R. Bernard, H. M. Neels, and J. R. Delanghe The Haptoglobin 2-2 Phenotype Affects Serum Markers of Iron Status in Healthy Males Clin. Chem., October 1, 2000; 46(10): 1619 - 1625. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M.A. Mahmoud, F. H. Comhaire, A. B. Christophe, C. Rolf, T.G. Cooper, and E. Nieschlag Oral antioxidants and male infertility Hum. Reprod., December 1, 1999; 14(12): 3149 - 3150. [Full Text] [PDF] |
||||
![]() |
J. Delanghe, M. Langlois, and M. De Buyzere Congenital Anhaptoglobinemia Versus Acquired Hypohaptoglobinemia Blood, May 1, 1998; 91(9): 3524 - 3524. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |